Shielding: what alpha actually requires
Alphas are stopped by paper or skin. The shielding decisions on an Ac-225 program are driven entirely by the daughter chain — particularly the Bi-213 gamma. Many programs initially over-spec wall shielding; the more common gap is at the bench and at the syringe.
Common misconceptions
“Alpha needs more wall shielding than Lu-177”
Generally false. The penetrating dose from Ac-225 (via Bi-213 gamma) at typical therapeutic activities is comparable to or less than from Lu-177 at the same activity. Wall shielding sized for an existing RLT program is usually adequate; verify with the AMP rather than assume in either direction.
“Light gloves are fine because alpha doesn’t penetrate”
Misleading. PPE is for contamination control, not penetrating dose. A speck of alpha-emitting material on skin or in a wound is the dominant hazard — that is what the gloves are for.
Where the shielding budget actually goes
Syringe shields & L-blocks
Tungsten or lead, thickness validated against Bi-213's 440 keV gamma by the AMP. The single highest-leverage shielding investment on an alpha program.
Vial pigs & transport containers
Sized for the daughter gamma at the activities the program actually handles. Verify with a calibrated survey meter on a known source before relying on vendor specs.
Hood / L-block geometry
Operator position relative to the source matters more than absolute mass. A small change in geometry often delivers more dose reduction than another centimeter of lead.
Shielding budget usually goes further on syringe shields, L-blocks, and vial pigs sized for Bi-213 than on adding lead to existing walls. Validating with the AMP using a calibrated meter on a known Ac-225 source before the first clinical dose is worth the time.